Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more
Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.010x
Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹6.43 Million) by net assets (₹668.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Visionary Copper and Gold Mines Inc.
F:CAX
|
-0.008x |
|
Prajay Engineers Syndicate Limited
NSE:PRAENG
|
0.052x |
|
Sterling Metals Corp
OTCQB:SAGGF
|
-0.027x |
|
Ostin Technology Group Co Ltd
NASDAQ:OST
|
-0.096x |
|
Dataprep Holdings Bhd
KLSE:8338
|
-0.158x |
|
Aeffe S.p.A.
LSE:0GY8
|
-0.060x |
|
IDT Australia Ltd
AU:IDT
|
-0.047x |
|
Poulaillon SA
PA:ALPOU
|
0.198x |
Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹624.69 Million | ₹48.92 Million | 0.078x | +68.23% |
| 2024-03-31 | ₹523.71 Million | ₹24.38 Million | 0.047x | -75.01% |
| 2023-03-31 | ₹438.43 Million | ₹81.67 Million | 0.186x | +18.60% |
| 2022-03-31 | ₹373.20 Million | ₹58.62 Million | 0.157x | +145.08% |
| 2021-03-31 | ₹324.58 Million | ₹-113.10 Million | -0.348x | -1175.78% |
| 2020-03-31 | ₹298.66 Million | ₹9.67 Million | 0.032x | -81.43% |
| 2019-03-31 | ₹282.36 Million | ₹49.24 Million | 0.174x | -8.75% |
| 2018-03-31 | ₹266.66 Million | ₹50.97 Million | 0.191x | +202.51% |
| 2017-03-31 | ₹163.72 Million | ₹-30.52 Million | -0.186x | +26.28% |
| 2016-03-31 | ₹147.44 Million | ₹-37.29 Million | -0.253x | -980.71% |
| 2015-03-31 | ₹136.14 Million | ₹-3.19 Million | -0.023x | -107.36% |
| 2014-03-31 | ₹85.72 Million | ₹27.27 Million | 0.318x | -21.78% |
| 2013-03-31 | ₹50.55 Million | ₹20.57 Million | 0.407x | -- |